Adamas Pharmaceuticals - Daily Chart

Name
*Data as of: 2017-10-31
Company Summary Adamas Pharmaceuticals, Inc. is a specialty pharmaceutical company driven to improve the lives of those affected by chronic disorders of the central nervous system. The company seeks to achieve this by modifying the pharmacokinetic profiles of approved drugs to create novel therapeutics for use alone and in fixed-dose combination products. Adamas is currently developing ADS-5102, its lead wholly-owned product candidate, for the treatment of levodopa-induced dyskinesia (LID) associated with Parkinson's disease and for the treatment of major symptoms associated with multiple sclerosis in patients with walking impairment. The company's portfolio also includes Namzaric and Namenda XR, two approved products with Forest Laboratories Holdings Limited, an indirect wholly-owned subsidiary of Allergan plc. Forest is responsible for marketing both products in the United States under an exclusive license from Adamas.
Daily Stock Data   Dates and Ratios   Company Background
Symbol ADMS Earnings Date 2017-11-01 Exchange NASDAQ
Name Adamas Pharmaceuticals Ex Dividend Date N/A Sector Medical
Close $24.66 Exp. Dividend Amount N/A Industry Medical - Biomed / Biotech
$ Change
+1.05
Dividend Yield 0.00 Market Cap 555M
% Change
+4.40%
Alpha 0.19 Enterprise Value 437M
Open 23.62 Beta 1.16 Shares 1000s 22,514
Days Range 22.88 - 24.88 Daily ATR 1.37 Incorp Date 2000
52 Week Range 12.10 - 24.55 Daily ATR% 5.56% IPO Date 2014-04-10
Volume 1,733,900 Price/Earnings 0.00 Location Emeryville,CA
Avg Vol 50d 1,320,040 Price/Book 4.20 ADR No
Vol % Chg vs 50 Day
+33.50%
Price/Sales 3084.42 Options Yes
Up/Down Volume 2.30 PEG 0.00 ETF/Closed End Fund No
AD Rating Timeliness Rating Industry Group Rank
Symbol Comp Rating EPS Rating SMR Rating RS Rating Sponsor Rating Current Last Week Current Last Week Ind Group RS Current Last Week 3 Months Ago 6 Months Ago Industry Group Sector
ADMS 53 7 E 96 B A- B- C C A+ 2 3 5 19 Medical-Biomed/Biotech MEDICAL
   
Stock Symbol   Sector   Industry Group
ADMS   Medical   Medical - Biomed / Biotech
Overall Stock Ratings   Stock Ratings within Sector   Stock Ratings within Industry
Full 18.59 Full 16.0095 Full 12.92
Earnings 4.01 Earnings 13.98 Earnings 20.71
Sales 6.37 Sales 5.34 Sales 5.57
Margins 19.76 Margins 49.30 Margins 60.13
Valuation 80.64 Valuation 74.59 Valuation 71.27
Best Rated Stocks Overall   Best Rated Stocks in Sector:
Medical
  Best Rated Stocks in Industry:
Medical - Biomed / Biotech
JP 100.00 ABMD 100.00 CORT 100.00
ESNT 99.98 CORT 99.87 SUPN 99.78
LRCX 99.96 ALGN 99.75 LGND 99.55
YY 99.94 FONR 99.62 VRTX 99.33
FB 99.92 HSKA 99.49 BIVV 99.11
*All ratings range from 0 to 100 with 100 being the highest.
 
Stock Symbol   Sector   Industry Group
ADMS   Medical   Medical - Biomed / Biotech
% Gain   Average Stock Gain % in Sector   Average Stock Gain % in Industry
1 Day
+4.40%
1 Day
+0.09%
1 Day
-0.61%
1 Week
+36.02%
1 Week
-1.48%
1 Week
-2.21%
2 Weeks
+29.65%
2 Weeks
-1.64%
2 Weeks
-5.33%
3 Weeks
+13.69%
3 Weeks
-1.01%
3 Weeks
-6.13%
1 Month
+14.38%
1 Month
-1.01%
1 Month
-5.29%
3 Months
+43.62%
3 Months
+5.23%
3 Months
+7.11%
6 Months
+49.91%
6 Months
+11.74%
6 Months
+19.45%
1 year
+72.09%
1 year
+28.80%
1 year
+42.57%
YTD
+45.92%
YTD
+27.09%
YTD
+42.32%
 
Sector Info   Sector Ranking   Average Stock Gain % in Sector
Symbol ADMS Current 20 1 Day
+0.09%
Sector Medical Yesterday 21 1 Week
-1.48%
Market Val(Bil) 4,283.83B 1 Week Ago 12 2 Weeks
-1.64%
Industry Groups 399 2 Week Ago 19 3 Week
-1.01%
Total Stocks 704 3 Week Ago 17 1 Month
-1.01%
New Highs 24 1 Month Ago 19 3 Month
+5.23%
New Highs % 3.41% 3 Month Ago 9 6 Months
+11.74%
New Lows 27 6 Month Ago 29 1 year
+28.80%
New Lows % 3.84% 1 Year Ago 31 YTD
+27.09%
 
Industry Group Info   Industry Group Ranking   Average Stock Gain % in Industry
Symbol ADMS Current 50 1 Day
-0.61%
Industry Group Medical - Biomed / Biotech Yesterday 67 1 Week
-2.21%
Market Val(Bil) 735.54B 1 Week Ago 42 2 Weeks
-5.33%
Total Stocks 399 2 Weeks Ago 22 3 Weeks
-6.13%
New Highs 9 3 Weeks Ago 22 1 Month
-5.29%
New Highs % 2.26% 1 Month Ago 25 3 Months
+7.11%
New Lows 15 3 Months Ago 16 6 Months
+19.45%
New Lows % 3.76% 6 Months Ago 104 1 Year
+42.57%
      1 Year Ago 154 YTD
+42.32%
Data as of: 2017-10-31
Daily Stock Data   Dates and Ratios   Company Background
Symbol ADMS Earnings Date 2017-11-01 Exchange NASDAQ
Name Adamas Pharmaceuticals Ex Dividend Date N/A Sector MEDICAL
Close 24.66 Exp. Dividend Amt N/A Industry Medical-Biomed/Biotech
$ Change 1.05 Dividend Yield 0 Market_Cap_mil 555.2
% Change 4.4 Alpha 0.19 Enterprise_Val_mil 437
Open 23.62 Beta 1.16 Shares_1000s 22514
Day's Range 22.88 - 24.88 Daily ATR 1.37 Incorp_Date 2000
52 Week Range 12.1 - 24.55 Daily ATR% 5.56 IPO Date 2014-04-10
Volume 173,390,000 Price/Earnings Location Emeryville,CA
Avg Vol 50d 132,004,000 Price/Book 4.2 ADR No
Short Volume 7,424,033 Price/Sales 3084.42 Options Yes
Shrt Int Pcnt Chg -2.3 PEG ETF/Closed End Fund No
Data as of: 2017-10-31
Daily Stock Data   Dates and Ratios   Company Background
Symbol ADMS Earnings Date 2017-11-01 Exchange NASDAQ
Name Adamas Pharmaceuticals Ex Dividend Date N/A Sector MEDICAL
Close 24.66 Exp. Dividend Amt N/A Industry Medical-Biomed/Biotech
$ Change 1.05 Dividend Yield 0 Market_Cap_mil 555.2
% Change 4.4 Alpha 0.19 Enterprise_Val_mil 437
Open 23.62 Beta 1.16 Shares_1000s 22514
Day's Range 22.88 - 24.88 Daily ATR 1.37 Incorp_Date 2000
52 Week Range 12.1 - 24.55 Daily ATR% 5.56 IPO Date 2014-04-10
Volume 173,390,000 Price/Earnings Location Emeryville,CA
Avg Vol 50d 132,004,000 Price/Book 4.2 ADR No
Short Volume 7,424,033 Price/Sales 3084.42 Options Yes
Shrt Int Pcnt Chg -2.3 PEG ETF/Closed End Fund No
Sales Ratings (0 to 10) Sales Accelerating % Sales Growth % Sales Growth Rank
Symbol Overall within Sector within Industry Annual Sales 2Q 3Q Last Qtr Last Yr 3 Years 5 Years Last Qtr Last Yr 3 Years 5 Years
ADMS 6.37 5.34 5.57 0.6M No No -70 -89 -73
Data as of: 2017-10-31
Daily Stock Data   Dates and Ratios   Company Background
Symbol ADMS Earnings Date 2017-11-01 Exchange NASDAQ
Name Adamas Pharmaceuticals Ex Dividend Date N/A Sector MEDICAL
Close 24.66 Exp. Dividend Amt N/A Industry Medical-Biomed/Biotech
$ Change 1.05 Dividend Yield 0 Market_Cap_mil 555.2
% Change 4.4 Alpha 0.19 Enterprise_Val_mil 437
Open 23.62 Beta 1.16 Shares_1000s 22514
Day's Range 22.88 - 24.88 Daily ATR 1.37 Incorp_Date 2000
52 Week Range 12.1 - 24.55 Daily ATR% 5.56 IPO Date 2014-04-10
Volume 173,390,000 Price/Earnings Location Emeryville,CA
Avg Vol 50d 132,004,000 Price/Book 4.2 ADR No
Short Volume 7,424,033 Price/Sales 3084.42 Options Yes
Shrt Int Pcnt Chg -2.3 PEG ETF/Closed End Fund No
Margins Ratings (0 to 10) Average After Tax Margins
Symbol Overall within Sector within Industry Pretax Margin Last Qtr After Tax Margin Accel 3Q After Tax Margin Last Qtr 2 Qtr 3 Qtr 4 Qtr 5 Qtr 6 Qtr
ADMS 19.76 49.3 60.13 -10519.8 No
 
Stock Symbol   Sector   Industry Group
ADMS   Medical   Medical - Biomed / Biotech
Ratios   Average Ratios in Sector   Average Ratios in Industry
Price/Earnings (PE) 0.00 Price/Earnings (PE) 70.87 Price/Earnings (PE) 220.10
Price/Book (PB) 4.20 Price/Book (PB) 3.20 Price/Book (PB) 5.66
Price/Sales (PS) 3084.42 Price/Sales (PS) 212.79 Price/Sales (PS) 412.66
Price/Cash Flow (PCF) -11.55 Price/Cash Flow (PCF) -2.57 Price/Cash Flow (PCF) -10.95
PEG 0.00 PEG 2.63 PEG 0.70
Dividend Adj PEG 0.00 Dividend Adj PEG 2.31 Dividend Adj PEG 0.69
Return on Equity (ROE) -48.40 Return on Equity (ROE) -91.54 Return on Equity (ROE) -130.23
Yield 0.00 Yield 1.25 Yield 1.74
Current Ratio 11.78 Current Ratio 5.75 Current Ratio 7.27
Debt % 0.00% Debt % 88.26% Debt % 45.95%
Long Term Debt/Work Capital 0.28 Long Term Debt/Work Capital 1.20 Long Term Debt/Work Capital 0.22
 
Stock ADMS   Exponential Moving Averages   Simple Moving Averages
Name Adamas Pharmaceuticals EMA 10 days
20.93(17.82%)
SMA 10 days
20.07(22.87%)
Close $24.66 EMA 20 days
20.57(19.88%)
SMA 20 days
20.56(19.94%)
$ Change
+1.05
EMA 50 days
20.02(23.18%)
SMA 50 days
20.46(20.53%)
% Change
+4.40%
EMA 89 days
19.27(27.97%)
SMA 79 days
19.04(29.52%)
Volume 1,733,900 EMA 100 days
19.10(29.11%)
SMA 100 days
18.69(31.94%)
Avg Volume 1,320,040 EMA 200 days
18.11(36.17%)
SMA 200 days
17.67(39.56%)
Vol% vs. Avg Vol
+33.50%
           
Up/Down Vol 2.30   Keltner Channel   Bollinger Band
Distribution Days 0   Upper
22.41(10.04%)
  Upper
24.51(0.61%)
ATR 1.37   Mid
20.63(19.53%)
  Mid
20.56(19.94%)
ATR% 5.56%   Lower
18.85(30.82%)
  Lower
16.60(48.55%)